OREBRIEF · SOURCE REPORT
Voyageur Pharmaceuticals Announces Proposed Issuance of Shares for Debt
Source: Newsfile · Reported September 24, 2026 · VM
At a glance
Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC Pink: VYYRF) ("Voyageur" or the "Company"), Canadian developer of pharmaceutical-grade barium and iodine contrast media for medical imaging, announces that it proposes to settle debts in the aggregate amount of $192,300 (the "Debt") through the issuance of common shares of the Company ("Common Shares") at a deemed price of $0.155 per Common Share, being the closing price of the Common Shares...
From the available Newsfile headline and excerpt. Company claims have not been independently verified.
Read the source
Open the original report at Newsfile ↗Why this story is ranked here · 4/100
- Source excerpt available
Editorial priority, not an investment rating. This is the public ranking; personal watchlists can add a small boost in your feed. Methodology →